Rhone Ma Holdings Bhd
KLSE:RHONEMA
Relative Value
The Relative Value of one RHONEMA stock under the Base Case scenario is hidden MYR. Compared to the current market price of 0.685 MYR, Rhone Ma Holdings Bhd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RHONEMA Competitors Multiples
Rhone Ma Holdings Bhd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MY |
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
151.5m MYR | 0.7 | 11.5 | 5.6 | 6.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 17.4 | 56.1 | 37.6 | 40.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.4B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
287.9B CHF | 4.7 | 30.7 | 12.9 | 15.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.4B USD | 4.6 | 15.7 | 11 | 13.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.6B CHF | 5.3 | 20.5 | 12.9 | 16.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP | 5.1 | 31.6 | 15.1 | 22.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13.1 | 9.2 | 10.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.8B USD | 2.4 | 15.4 | 7.8 | 10.6 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.9B EUR | 1.8 | 8.3 | 7.7 | 7.7 |